$27.23
0.98% today
NYSE, Oct 14, 09:16 pm CET
ISIN
US5004723038
Symbol
PHG

Royal Philips NV Sponsored ADR Stock price

$27.50
-0.67 2.38% 1M
+3.71 15.59% 6M
+2.18 8.61% YTD
-4.88 15.07% 1Y
+14.78 116.23% 3Y
-17.24 38.53% 5Y
+4.63 20.23% 10Y
+4.15 17.79% 20Y
NYSE, Closing price Mon, Oct 13 2025
+0.17 0.62%

Key metrics

Basic
Market capitalization
$26.1b
Enterprise Value
$33.7b
Net debt
$7.6b
Cash
$2.1b
Shares outstanding
950.6m
Valuation (TTM | estimate)
P/E
137.5 | 17.1
P/S
1.3 | 1.2
EV/Sales
1.6 | 1.6
EV/FCF
67.1
P/B
2.2
Dividends
DPS
$0.97
Yield 1Y | 5Y
3.5% | 1.8%
Growth 1Y | 5Y
100.0% | -
Payout 1Y | 3Y
-111.2% | -28.5%
Increased
1 Year
Financials (TTM | estimate)
Revenue
$20.7b | $21.1b
EBITDA
$2.8b | $3.4b
EBIT
$1.3b | $2.2b
Net Income
$187.5m | $1.5b
Free Cash Flow
$502.2m
Growth (TTM | estimate)
Revenue
-1.5% | 0.9%
EBITDA
140.0% | 23.5%
EBIT
476.2% | 98.4%
Net Income
138.5% | 288.4%
Free Cash Flow
-61.8%
Margin (TTM | estimate)
Gross
43.9%
EBITDA
13.4% | 16.0%
EBIT
6.1%
Net
0.9% | 7.3%
Free Cash Flow
2.4%
Financial Health
Equity Ratio
41.4%
Return on Equity
-5.9%
ROCE
5.7%
ROIC
1.1%
Debt/Equity
0.8
More
EPS
$0.2
FCF per Share
$0.5
Short interest
0.1%
Employees
67k
Rev per Employee
$310.0k
Show more

Is Royal Philips NV Sponsored ADR a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,002 stocks worldwide.

Royal Philips NV Sponsored ADR Stock Analysis

Unlock Scores for Free

Analyst Opinions

27 Analysts have issued a Royal Philips NV Sponsored ADR forecast:

15x Buy
56%
12x Hold
44%

Analyst Opinions

27 Analysts have issued a Royal Philips NV Sponsored ADR forecast:

Buy
56%
Hold
44%

Financial data from Royal Philips NV Sponsored ADR

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
20,663 20,663
2% 2%
100%
- Direct Costs 11,603 11,603
5% 5%
56%
9,060 9,060
4% 4%
44%
- Selling and Administrative Expenses 5,830 5,830
2% 2%
28%
- Research and Development Expense 2,041 2,041
2% 2%
10%
2,761 2,761
140% 140%
13%
- Depreciation and Amortization 1,499 1,499
1% 1%
7%
EBIT (Operating Income) EBIT 1,262 1,262
476% 476%
6%
Net Profit 187 187
138% 138%
1%

In millions USD.

Don't miss a Thing! We will send you all news about Royal Philips NV Sponsored ADR directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Royal Philips NV Sponsored ADR Stock News

Neutral
GlobeNewsWire
6 days ago
October 8, 2025 Global adoption milestone underscores innovation in mobile C-arm surgical and interventional imaging, with more than 15 million patients treated in 170+ countries every year Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the 5,000th installation of its Philips Zenition mobile surgery imaging system at Kolí...
Neutral
PRNewsWire
8 days ago
DUBAI, UAE, Oct. 7, 2025 /PRNewswire/ --  Royal Philips  (NYSE: PHG) (AEX: PHIA), a global leader in health technology, has released the second edition of The Philips Health Trends Research UAE. Conducted by market research firm Censuswide, the study explores people's perceptions across key aspects of health.
Neutral
GlobeNewsWire
15 days ago
ONTARIO, Calif., Sept. 29, 2025 (GLOBE NEWSWIRE) -- The official Philips Home Access online store has been launched at homeaccess.philips , offering U.S. consumers direct access to a full range of keyless smart locks and home security solutions.
More Royal Philips NV Sponsored ADR News

Company Profile

Royal Philips NV is a technology company, which engages in the healthcare, lighting, and consumer well-being markets. It operates through the following segments: Personal Health, Diagnosis & Treatment, Connected Care & Health Informatics, and Other. The Personal Health segment focuses on healthy living and preventative care. This segment comprises the Personal Care, Domestic Appliances, Oral Healthcare, and Mother & Child Care businesses. The Diagnosis & Treatment segment unites the businesses related to the promise of precision diagnosis and disease pathway selection, and the businesses related to image-guided, minimally invasive treatments. This segment comprises the Diagnostic Imaging, Ultrasound, Healthcare Informatics and Image-Guided Therapy businesses. The Connected Care & Health Informatics segment focuses on patient care solutions, advanced analytics and patient and workflow optimization inside and outside the hospital, and aims to unlock synergies from integrating and optimizing patient care pathways and leveraging provider-payer-patient business models. This segment comprises the Monitoring & Analytics, Therapeutic Care, Population Health Management, and Sleep & Respiratory Care businesses. The Other segment reports on the items Innovation & Strategy, IP Royalties, Central costs, and other small items. The company was founded by Anton Frederik Philips and Gerard Leonard Frederik Philips in 1891 and is headquartered in Amsterdam, the Netherlands.

Head office Netherlands
CEO Roy Jakobs
Employees 66,678
Founded 1891
Website www.philips.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today